These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

813 related articles for article (PubMed ID: 9810002)

  • 1. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression.
    Wolf J; Pawlita M; Bullerdiek J; zur Hausen H
    Cancer Res; 1990 May; 50(10):3095-100. PubMed ID: 2159373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
    Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
    Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell phenotype-dependent splicing reflecting differential promoter usage for EBNA transcripts in EBV-carrying cells.
    Hu LF; Chen F; Altiok E; Winberg G; Klein G; Ernberg I
    Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():248-60. PubMed ID: 10895161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Steel CM; Morten JE; Foster E
    IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells.
    Wolf J; Draube A; Bohlen H; Jox A; Mücke S; Pawlita M; Möller P; Diehl V
    Int J Cancer; 1995 Feb; 60(4):527-33. PubMed ID: 7829268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive, metastatic growth of lymphoblastoid B cells in immunodeficient SCID mice].
    Walter J; Wolf J; Pawlita M; Schirrmacher V; Moldenhauer G; Möller P
    Verh Dtsch Ges Pathol; 1991; 75():224-8. PubMed ID: 1724838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regressing nude mouse grafts of Burkitt's lymphoma x lymphoblastoid cell hybrids show deregulation of the c-myc gene and expression of the EBV latent membrane protein.
    Wolf J; Klevenz B; Pawlita M; Komitowski D; Moldenhauer G; zur Hausen H
    Int J Cancer; 1991 Jan; 47(1):99-104. PubMed ID: 1702406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
    Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
    Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
    Benedict WF; Weissman BE; Mark C; Stanbridge EJ
    Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B cell lines by cytokines and CD4+ T cells.
    Gauchat JF; Gascan H; de Waal Malefyt R; de Vries JE
    J Immunol; 1992 Apr; 148(7):2291-9. PubMed ID: 1347554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of tumorigenicity in an EBV-converted Burkitt's lymphoma line.
    Klein G
    Ciba Found Symp; 1989; 142():36-48; discussion 48-53. PubMed ID: 2545422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of tumorigenicity in hybrids of tumorigenic Chinese hamster cells and diploid mouse fibroblasts: dependence on the presence of at least three different mouse chromosomes and independence of hamster genome dosage.
    Schäfer R; Hoffmann H; Willecke K
    Cancer Res; 1983 May; 43(5):2240-6. PubMed ID: 6831446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Epstein-Barr virus latent gene expression on the apoptosis-inducing effects of cortisone and 2-chlorodeoxyadenosine (2-CDA) in B-cell lines.
    Röth A; Pfaff P; Lange W; Finke J
    Cytokines Mol Ther; 1996 Mar; 2(1):21-8. PubMed ID: 9384686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory function of human leukemic cell lines: properties of B and B-K562 hybrid cell lines.
    Wakasugi H; Dokhelar MC; Garson D; Harel-Bellan A; Fradelizi D; Tursz T
    Eur J Immunol; 1985 Mar; 15(3):256-61. PubMed ID: 3872216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
    Klinger HP; Shows TB
    J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of an activated b lymphocyte-associated surface moiety defined by the B2 monoclonal antibody by ebv conversion of an EBV-negative lymphoma line (Ramos): differential effect of transforming (B95-8) and nontransforming (P3HR-1) EBV substrains.
    Klein G; Ehlin-Henriksson B; Schlossman SF
    J Immunol; 1983 Apr; 130(4):1985-9. PubMed ID: 6300235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hybridization of a myeloid leukemia-derived human cell line (K562) with a human Burkitt's lymphoma line (P3HR-1).
    Klein G; Zeuthen J; Eriksson I; Terasaki P; Bernoco M; Rosén A; Masucci G; Povey S; Ber R
    J Natl Cancer Inst; 1980 Apr; 64(4):725-38. PubMed ID: 6245297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis.
    Seagon S; Dürst M
    Cancer Res; 1994 Nov; 54(21):5593-8. PubMed ID: 7923202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.